GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (NAS:ACHV) » Definitions » Shiller PE Ratio

ACHV (Achieve Life Sciences) Shiller PE Ratio : (As of Apr. 11, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Achieve Life Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Achieve Life Sciences Shiller PE Ratio Historical Data

The historical data trend for Achieve Life Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences Shiller PE Ratio Chart

Achieve Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Achieve Life Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Achieve Life Sciences's Shiller PE Ratio

For the Biotechnology subindustry, Achieve Life Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Achieve Life Sciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Achieve Life Sciences's Shiller PE Ratio falls into.


;
;

Achieve Life Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Achieve Life Sciences's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Achieve Life Sciences's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.36/133.1571*133.1571
=-0.360

Current CPI (Dec. 2024) = 133.1571.

Achieve Life Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -440.000 99.621 -588.120
201506 -572.001 100.684 -756.486
201509 -352.000 100.392 -466.885
201512 -132.000 99.792 -176.133
201603 -264.000 100.470 -349.889
201606 -506.001 101.688 -662.591
201609 -264.000 101.861 -345.112
201612 -418.000 101.863 -546.419
201703 -14.990 102.862 -19.405
201706 -12.132 103.349 -15.631
201709 -179.200 104.136 -229.141
201712 -62.606 104.011 -80.149
201803 -48.600 105.290 -61.463
201806 -36.400 106.317 -45.589
201809 -14.200 106.507 -17.753
201812 -11.000 105.998 -13.818
201903 -17.600 107.251 -21.851
201906 -10.080 108.070 -12.420
201909 -9.070 108.329 -11.149
201912 -6.000 108.420 -7.369
202003 -2.150 108.902 -2.629
202006 -1.680 108.767 -2.057
202009 -1.140 109.815 -1.382
202012 -0.773 109.897 -0.937
202103 -1.300 111.754 -1.549
202106 -1.530 114.631 -1.777
202109 -0.710 115.734 -0.817
202112 -0.760 117.630 -0.860
202203 -0.800 121.301 -0.878
202206 -1.080 125.017 -1.150
202209 -1.350 125.227 -1.435
202212 -0.830 125.222 -0.883
202303 -0.500 127.348 -0.523
202306 -0.430 128.729 -0.445
202309 -0.340 129.860 -0.349
202312 -0.240 129.419 -0.247
202403 -0.260 131.776 -0.263
202406 -0.250 132.554 -0.251
202409 -0.360 133.029 -0.360
202412 -0.360 133.157 -0.360

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Achieve Life Sciences  (NAS:ACHV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Achieve Life Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Achieve Life Sciences Business Description

Traded in Other Exchanges
Address
22722 29th Drive SE, Suite 1000, Bothell, WA, USA, 98021
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Executives
Richard Alistair Stewart director, officer: President & CEO 19820 NORTH CREEK PARKWAY, SUITE 201, BOTHELL WA 98011
John Bencich officer: CFO and PFO 2401 FOURTH AVENUE, SUITE 1050, SEATTLE WA 98121
Stuart Duty director 22722 29TH DR SE, SUITE 100, BOTHELL WA 98021
Thomas Sellig director 22722 29TH DR SE, SUITE 100, BOTHELL WA 98021
Thomas Braxton King director 91 JAMES AVENUE, ATHERTON CA 94027
Dialectic Life Sciences Spv Llc 10 percent owner C/O DIALECTIC LS MANAGER LLC, 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
Dialectic Ls Manager Llc 10 percent owner 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
John Fichthorn 10 percent owner C/O DIALECTIC CAPITAL MANAGEMENT, LLC, 17 STATE STREET, SUITE 3930, NEW YORK NY 10004
Dialectic Capital Management, Lp 10 percent owner 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
Dialectic Partners, Llc 10 percent owner 2ND FLOOR 119 ROWAYTON AVE, NORWALK CT 06853
Vaughn B Himes director C/O SEATTLE GENETICS, INC., 21823 30TH DRIVE SE, BOTHELL WA 98021
Financial Group Svb 10 percent owner 2270 SAND HILL ROAD, MENLO PARK CA 94025
Svb Innovation Credit Partners Viii, Llc 10 percent owner 2770 SAND HILL ROAD, MENLO CITY CA 94025
Svb Innovation Credit Fund Viii, L.p. 10 percent owner C/O SVB INNOVATION CREDIT PARTNERS VIII, 2770 SAND HILL ROAD, MENLO PARK CA 94025
Innovation Credit Fund Viii-a, L.p. 10 percent owner 2770 SAND HILL ROAD, MENLO PARK CA 94025